Paul Rutherford Carter Insider Trading $GILD GILEAD SCIENCES INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paul Rutherford Carter.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul Rutherford Carter. Paul Rutherford Carter is EVP Commercial Ops in GILEAD SCIENCES INC ($GILD).
Paul Rutherford Carter in GILEAD SCIENCES INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Paul Rutherford Carter: EVP Commercial Ops
Holdings: 45,439 shares
Current Value: $3,322,954
Latest Transaction: Feb 19 2015
$GILD Market Capitalization: $88.05B
$GILD Previous Close: $73.13
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Paul Rutherford Carter in GILEAD SCIENCES INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Payment of Exercise | F | 103.84 | 16,157 | 1,677,743 | 45,439 | 61.6 K to 45.4 K (-26.23 %) |
| Feb 19 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Grant | A | 0.00 | 19,200 | 0 | 61,596 | 42.4 K to 61.6 K (+45.29 %) |
| Feb 19 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Grant | A | 0.00 | 7,840 | 0 | 42,396 | 34.6 K to 42.4 K (+22.69 %) |
| Feb 19 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Grant | A | 85.61 | 248 | 21,232 | 34,556 | 34.3 K to 34.6 K (+0.72 %) |
| Feb 04 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 80.65 | 2,000 | 161,300 | 36,640 | |
| Feb 04 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 106.16 | 2,000 | 212,310 | 34,308 | 36.3 K to 34.3 K (-5.51 %) |
| Feb 04 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 80.65 | 2,000 | 161,300 | 36,308 | 34.3 K to 36.3 K (+5.83 %) |
| Feb 03 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | A | 104.83 | 44,300 | 4,643,969 | 44,300 | |
| Jan 12 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 717 | 29,082 | 17,523 | |
| Jan 12 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 26.99 | 283 | 7,638 | 23,981 | |
| Jan 12 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 100.88 | 1,000 | 100,881 | 34,308 | 35.3 K to 34.3 K (-2.83 %) |
| Jan 12 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 26.99 | 283 | 7,638 | 35,308 | 35 K to 35.3 K (+0.81 %) |
| Jan 12 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 717 | 29,082 | 35,025 | 34.3 K to 35 K (+2.09 %) |
| Jan 06 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 1,000 | 40,560 | 18,240 | |
| Jan 06 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 95.05 | 1,000 | 95,050 | 34,308 | 35.3 K to 34.3 K (-2.83 %) |
| Jan 06 2015 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 1,000 | 40,560 | 35,308 | 34.3 K to 35.3 K (+2.91 %) |
| Dec 03 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 2,000 | 81,120 | 19,240 | |
| Dec 03 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 100.02 | 2,000 | 200,031 | 34,308 | 36.3 K to 34.3 K (-5.51 %) |
| Dec 03 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 2,000 | 81,120 | 36,308 | 34.3 K to 36.3 K (+5.83 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 0.00 | 4,800 | 0 | 12,500 | |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 3,000 | 121,680 | 21,240 | |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Payment of Exercise | F | 109.72 | 2,736 | 300,194 | 34,308 | 31.6 K to 34.3 K (+8.67 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 0.00 | 4,800 | 0 | 37,044 | 32.2 K to 37 K (+14.89 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 112.46 | 3,000 | 337,380 | 32,244 | 35.2 K to 32.2 K (-8.51 %) |
| Nov 05 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 3,000 | 121,680 | 35,244 | 32.2 K to 35.2 K (+9.30 %) |
| Oct 28 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 2,000 | 81,120 | 24,240 | |
| Oct 28 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 110.00 | 2,000 | 220,007 | 32,244 | 34.2 K to 32.2 K (-5.84 %) |
| Oct 28 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 2,000 | 81,120 | 34,244 | 32.2 K to 34.2 K (+6.20 %) |
| Oct 03 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 2,000 | 81,120 | 26,240 | |
| Oct 03 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 106.39 | 2,000 | 212,785 | 32,244 | 34.2 K to 32.2 K (-5.84 %) |
| Oct 03 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 2,000 | 81,120 | 34,244 | 32.2 K to 34.2 K (+6.20 %) |
| Sep 30 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 2,000 | 81,120 | 28,240 | |
| Sep 30 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 107.47 | 2,000 | 214,945 | 32,244 | 34.2 K to 32.2 K (-5.84 %) |
| Sep 30 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 2,000 | 81,120 | 34,244 | 32.2 K to 34.2 K (+6.20 %) |
| Aug 28 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 19.09 | 10,000 | 190,850 | 15,200 | |
| Aug 28 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 106.16 | 10,000 | 1,061,618 | 32,244 | 42.2 K to 32.2 K (-23.67 %) |
| Aug 28 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 19.09 | 10,000 | 190,850 | 42,244 | 32.2 K to 42.2 K (+31.01 %) |
| Aug 28 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Grant | A | 21.94 | 259 | 5,684 | 32,244 | 32 K to 32.2 K (+0.81 %) |
| Aug 12 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 26.99 | 16,728 | 451,489 | 24,264 | |
| Aug 12 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 92.04 | 1,303 | 119,930 | 31,985 | 33.3 K to 32 K (-3.91 %) |
| Aug 12 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 91.54 | 15,425 | 1,411,951 | 33,288 | 48.7 K to 33.3 K (-31.67 %) |
| Aug 12 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 26.99 | 16,728 | 451,489 | 48,713 | 32 K to 48.7 K (+52.30 %) |
| Aug 05 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 0.00 | 2,500 | 0 | 17,300 | |
| Aug 05 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Payment of Exercise | F | 91.50 | 1,220 | 111,630 | 31,985 | 33.2 K to 32 K (-3.67 %) |
| Aug 05 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 0.00 | 2,500 | 0 | 33,205 | 30.7 K to 33.2 K (+8.14 %) |
| Jul 10 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 26.99 | 16,728 | 451,489 | 40,992 | |
| Jul 10 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 86.45 | 16,728 | 1,446,074 | 30,705 | 47.4 K to 30.7 K (-35.27 %) |
| Jul 10 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 26.99 | 16,728 | 451,489 | 47,433 | 30.7 K to 47.4 K (+54.48 %) |
| Jun 11 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 26.99 | 16,728 | 451,489 | 57,720 | |
| Jun 11 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 80.89 | 2,000 | 161,772 | 30,705 | 32.7 K to 30.7 K (-6.12 %) |
| Jun 11 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 80.04 | 2,020 | 161,690 | 32,705 | 34.7 K to 32.7 K (-5.82 %) |
| Jun 11 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 79.10 | 12,708 | 1,005,182 | 34,725 | 47.4 K to 34.7 K (-26.79 %) |
| Jun 11 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 26.99 | 16,728 | 451,489 | 47,433 | 30.7 K to 47.4 K (+54.48 %) |
Page: 1